Concepedia

Harri Lempiäinen

HL

15

Publications

1.1K

Citations

15

H-Index

2004

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Edinburgh

Institute of Genetics and Cancer

University of Tübingen

Harri Lempiäinen is an author at Novartis (Switzerland) specializing in medicine, systems biology, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2018

15

Publications

15

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

Martin Widschwendter, Michal Zikán, Benjamin Wahl et al. · Genome Medicine · 2017 · 170 citations · Full text

Sfp1 Interaction with TORC1 and Mrs6 Reveals Feedback Regulation on TOR Signaling

Harri Lempiäinen, Aino Uotila, Jörg Urban et al. · Molecular Cell · 2009 · 162 citations · Full text

, , +6

Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver

John P. Thomson, Jennifer M. Hunter, Harri Lempiäinen et al. · Nucleic Acids Research · 2013 · 89 citations · Full text

, , +28

Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice

Harri Lempiäinen, Arne Müller, Sarah Brasa et al. · PLoS ONE · 2011 · 84 citations · Full text

, , +19

Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome

John P. Thomson, Harri Lempiäinen, Jamie A. Hackett et al. · Genome biology · 2012 · 80 citations · Full text

Rows per page

1–5 of 15